Biofrontera Inc. to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
Biofrontera (NASDAQ:BFRI), a biopharmaceutical company focused on dermatological products commercialization, has announced its participation in the upcoming Lytham Partners Fall 2025 Investor Conference on September 30, 2025.
The company will deliver a webcast presentation at 1:15 p.m. ET and conduct one-on-one meetings with investors throughout the virtual event. Investors can access the webcast through the conference website or directly via the provided link, with replay available after the event.
Biofrontera (NASDAQ:BFRI), un'azienda biopharma focalizzata sulla commercializzazione di prodotti dermatologici, ha annunciato la propria partecipazione al prossimo Lytham Partners Fall 2025 Investor Conference del 30 settembre 2025. L'azienda terrà una presentazione in webcast alle 13:15 ora ET e svolgerà riunioni one-to-one con gli investitori durante l'evento virtuale. Gli investitori possono accedere al webcast tramite il sito della conferenza o direttamente tramite il collegamento fornito, con la registrazione disponibile dopo l'evento.
Biofrontera (NASDAQ:BFRI), una compañía biofarmacéutica centrata sulla comercialización de productos dermatológicos, ha anunciado su participación en la próxima Lytham Partners Fall 2025 Investor Conference el 30 de septiembre de 2025. La empresa llevará a cabo una presentación en webcast a las 1:15 p.m. ET y realizará reuniones one-to-one con inversores a lo largo del evento virtual. Los inversores pueden acceder al webcast a través del sitio de la conferencia o directamente mediante el enlace proporcionado, con la reproducción disponible después del evento.
Biofrontera (NASDAQ:BFRI)는 피부과 의약품의 상용화에 집중하는 생물의약 기업으로, 2025년 9월 30일에 열리는 Lytham Partners Fall 2025 Investor Conference 참가를 발표했습니다. 회사는 동부 표준시 13:15에 웹캐스트 발표를 진행하고 가상 행사 전 기간 동안 투자자들과 일대일 미팅을 수행합니다. 투자자들은 컨퍼런스 웹사이트를 통해 또는 제공된 링크를 통해 웹캐스트에 접속할 수 있으며, 이벤트 후 재방송이 제공됩니다.
Biofrontera (NASDAQ:BFRI), société biopharmaceutique axée sur la commercialisation de produits dermatologiques, a annoncé sa participation à la prochaine Lytham Partners Fall 2025 Investor Conference le 30 septembre 2025. L'entreprise organisera une présentation en webcast à 13h15 HE et mènera des réunions en face à face avec les investisseurs tout au long de l'événement virtuel. Les investisseurs pourront accéder au webcast via le site de la conférence ou directement via le lien fourni, avec la rediffusion disponible après l'événement.
Biofrontera (NASDAQ:BFRI), ein Biopharma-Unternehmen mit Fokus auf den Vertrieb dermatologischer Produkte, hat seine Teilnahme an der bevorstehenden Lytham Partners Fall 2025 Investor Conference am 30. September 2025 angekündigt. Das Unternehmen wird eine Webcast-Präsentation um 13:15 Uhr ET durchführen und im Verlauf der virtuellen Veranstaltung Einzelgespräche mit Investoren führen. Investoren können den Webcast über die Konferenz-Website oder direkt über den bereitgestellten Link aufrufen; eine Wiederholung wird nach der Veranstaltung verfügbar sein.
Biofrontera (NASDAQ:BFRI)، شركة أدوية حيوية تركز على تسويق منتجات جلدية، أعلنت عن مشاركتها في Lytham Partners Fall 2025 Investor Conference القادمة في 30 سبتمبر 2025. ستقوم الشركة بعرض بث ويب مباشر في الساعة 1:15 مساءً بتوقيت شرق الولايات المتحدة وإجراء اجتماعات ثنائية مع المستثمرين طوال الحدث الافتراضي. يمكن للمستثمرين الوصول إلى البث عبر موقع المؤتمر أو مباشرة عبر الرابط المقدم، مع توفر إعادة التشغيل بعد الحدث.
Biofrontera (NASDAQ:BFRI)，一家专注于皮肤科产品商业化的生物制药公司，宣布参与将于2025年9月30日举行的 Lytham Partners Fall 2025 Investor Conference。公司将于美国东部时间13:15进行网络直播演示，并在整个虚拟活动中与投资者进行一对一会谈。投资者可通过会议网站访问网络直播，或直接通过提供的链接访问，活动结束后提供回放。
- None.
- None.
Woburn, MA, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc., (Nasdaq:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the commercialization of dermatological products, today announced that it will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2025 Investor Conference, taking place virtually on Tuesday, September 30, 2025.
Company Webcast
The webcast presentation will take place at 1:15 p.m. ET on Tuesday, September 30, 2025. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/fall2025/ or directly at https://app.webinar.net/wWqPp4Yr0kD. The webcast will also be available for replay following the event.
1x1 Meetings
Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at 1x1@lythampartners.com or register for the event at https://lythampartners.com/fall2025invreg/.
About Biofrontera Inc.
Biofrontera Inc. is a U.S.-based biopharmaceutical company specializing in the development and treatment of dermatological conditions with a focus on PDT. The Company commercializes the drug-device combination Ameluz ® with the RhodoLED ® lamp series for PDT of AK, pre-cancerous skin lesions which may progress to invasive skin cancers. The Company performs clinical trials to extend the use of the products to treat non-melanoma skin cancers and moderate to severe acne. For more information, visit www.biofrontera-us.com and follow Biofrontera on LinkedIn and X.
Investor Relations Contact
Ben Shamsian
Lytham Partners
646-829-9701
shamsian@lythampartners.com
FAQ
When is Biofrontera (BFRI) presenting at the Lytham Partners Fall 2025 Conference?
How can investors access Biofrontera's (BFRI) conference presentation?
Will Biofrontera (BFRI) management be available for individual meetings during the conference?
What type of company is Biofrontera (BFRI)?
